- Home
- REPL vs CABO Comparison
REPL vs CABO Comparison
Compare REPL & CABO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- CABO
- Stock Information
- Founded
- REPL 2015
- CABO 1980
- Country
- REPL United States
- CABO United States
- Employees
- REPL 479
- CABO N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- CABO Cable & Other Pay Television Services
- Sector
- REPL Health Care
- CABO Telecommunications
- Exchange
- REPL Nasdaq
- CABO Nasdaq
- Market Cap
- REPL 239.0M
- CABO 717.5M
- IPO Year
- REPL 2018
- CABO N/A
- Fundamental
- Price
- REPL $3.15
- CABO $144.15
- Analyst Decision
- REPL Buy
- CABO Hold
- Analyst Count
- REPL 10
- CABO 3
- Target Price
- REPL $8.25
- CABO $231.00
- AVG Volume (30 Days)
- REPL 9.2M
- CABO 213.0K
- Earning Date
- REPL 08-07-2025
- CABO 07-31-2025
- Dividend Yield
- REPL N/A
- CABO 6.14%
- EPS Growth
- REPL N/A
- CABO N/A
- EPS
- REPL N/A
- CABO N/A
- Revenue
- REPL N/A
- CABO $1,555,831,000.00
- Revenue This Year
- REPL N/A
- CABO N/A
- Revenue Next Year
- REPL N/A
- CABO N/A
- P/E Ratio
- REPL N/A
- CABO N/A
- Revenue Growth
- REPL N/A
- CABO N/A
- 52 Week Low
- REPL $2.68
- CABO $117.54
- 52 Week High
- REPL $17.00
- CABO $437.00
- Technical
- Relative Strength Index (RSI)
- REPL 24.82
- CABO 53.85
- Support Level
- REPL $2.68
- CABO $117.54
- Resistance Level
- REPL $3.85
- CABO $159.36
- Average True Range (ATR)
- REPL 0.80
- CABO 7.13
- MACD
- REPL -1.03
- CABO 3.80
- Stochastic Oscillator
- REPL 4.45
- CABO 63.64
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About CABO Cable One Inc.
Cable One Inc. is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. From a product standpoint, the majority of revenue comes from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols. Cable One Inc. owns its telecommunications infrastructure.